Ifigenia Kostoglou Athanassiou | Immunology and Endocrinology | Research Excellence Award

Research Excellence Award

Ifigenia Kostoglou Athanassiou
Department of Endocrinology, Asklepeion General Hospital

Ifigenia Kostoglou Athanassiou
Affiliation Department of Endocrinology, Asklepeion General Hospital
Country Greece
Scopus ID 6701404681
Citations 1,186ย  citations by 56 documents
h-index 18
Subject Area Immunology and Endocrinology
Event International Environmental Scientists Award
ORCID
0000-0002-2029-8372

Ifigenia Kostoglou Athanassiou is a Greek endocrinologist affiliated with the Department of Endocrinology at Asklepeion General Hospital. Her scholarly profile demonstrates sustained contributions to endocrinology, autoimmune disorders, and metabolic disease research through peer-reviewed publications, clinical investigations, and interdisciplinary scientific engagement.[1] Her academic record reflects continuing involvement in endocrine and immunological research areas relevant to modern healthcare systems and translational medical science.[2]

Abstract

This academic article presents a structured overview of the scientific profile and research achievements of Ifigenia Kostoglou-Athanassiou. The article summarizes her institutional affiliation, scholarly metrics, research focus areas, and contributions to endocrine and immunological sciences. It additionally evaluates the relevance of her scientific work in the context of the International Environmental Scientists Award. The analysis incorporates bibliometric indicators, selected publications, and broader academic impact indicators associated with endocrinology and immune-related disorders.[1][3]

Keywords

Endocrinology; Immunology; Autoimmune Diseases; Metabolic Disorders; Clinical Research; Endocrine Science; Academic Recognition; Translational Medicine; Hormonal Disorders; Research Excellence Award

Introduction

Endocrinology and immunology remain central disciplines within contemporary medical research due to their influence on metabolic regulation, inflammatory disorders, and chronic disease management. Researchers operating at the intersection of these domains contribute substantially to diagnostic advancement and therapeutic innovation.[4] Ifigenia Kostoglou-Athanassiou has participated in scientific investigations concerning endocrine disorders and related immunological mechanisms, contributing to broader clinical understanding within these areas.[2]

Her publication profile and citation metrics indicate a sustained record of academic productivity. Through clinical and research activities at Asklepeion General Hospital, her work has addressed endocrine dysfunctions, autoimmune associations, and metabolic complications affecting patient health outcomes.[5]

Research Profile

Kostoglou-Athanassiou maintains an established academic presence within endocrine and immunological sciences. According to indexed bibliographic records, her scholarly output includes 56 documents and more than one thousand citations, with an h-index of 18.[1] These indicators demonstrate measurable research visibility and continued scholarly engagement within the international scientific community.

Her research interests encompass autoimmune endocrinopathies, metabolic dysfunctions, thyroid disease, inflammatory responses, and hormonal regulation. The integration of clinical practice with academic investigation has enabled the development of research perspectives grounded in evidence-based medicine and patient-centered endocrinology.[6]

Research Contributions

The scientific contributions ofย  Kostoglou-Athanassiou include investigations into endocrine autoimmune disorders, inflammatory markers, metabolic syndrome, and hormonal interactions affecting systemic physiology.[7] Her research activities have contributed to improved understanding of endocrine complications associated with chronic disease and immune-mediated conditions.

Several of her studies have focused on the relationship between endocrine signaling pathways and inflammatory responses, particularly in conditions involving thyroid dysfunction and metabolic abnormalities.[8] Such investigations are relevant to contemporary healthcare challenges involving obesity, diabetes, autoimmune pathology, and systemic inflammation.

Her publication record additionally reflects interdisciplinary scientific collaboration and participation in peer-reviewed medical literature. The continued dissemination of endocrine research findings through indexed journals has strengthened scientific dialogue concerning diagnostic methodologies and therapeutic approaches.[9]

Publications

The Scopus profile lists 10 documents associated with Susanta Mandal [1]. Indexed publications play an important role in academic visibility because they allow research outputs to be discovered, cited, and evaluated within international scholarly databases.

Research Impact

The research impact associated with Kostoglou-Athanassiou is reflected through citation performance, publication continuity, and interdisciplinary scientific relevance. Her work contributes to medical understanding within endocrinology and related immune-mediated conditions, supporting both clinical application and ongoing academic investigation.[1]

The integration of immunological concepts into endocrine research is increasingly important for addressing chronic metabolic disease and inflammatory disorders. Her academic contributions align with broader healthcare objectives involving evidence-based medicine, translational science, and improved patient care outcomes.[10]

Award Suitability

Ifigenia Kostoglou-Athanassiou demonstrates several characteristics commonly associated with recipients of international scientific recognition awards. These include sustained scholarly productivity, peer-reviewed publication output, measurable citation impact, and continued engagement in clinically relevant research domains.[3]

Her scientific profile aligns with the objectives of the International Environmental Scientists Award through interdisciplinary medical research addressing metabolic health, systemic inflammatory mechanisms, and chronic disease interactions relevant to public health and environmental influences on human physiology.[11]

Conclusion

Ifigenia Kostoglou-Athanassiou represents an established academic contributor within endocrinology and immunological medical research. Her scholarly record, institutional affiliation, citation performance, and interdisciplinary investigations collectively demonstrate continued participation in scientific advancement. The integration of endocrine and immune-related research themes within her work supports broader clinical and public health objectives associated with evidence-based medical science and translational healthcare research.[1][5]

Reference

  1. Elsevier. (n.d.).ย Scopus author details: Ifigenia Kostoglou-Athanassiou, Author ID 6701404681.ย Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6701404681
  2. Medicina Lithuania. (2025).ย Euthyroid Sick Syndrome as an Index of Prognosis in Severe COVID-19 Disease.
    https://doi.org/10.3390/medicina
  3. Review Article.ย Targeted Cellular Treatment of Systemic Lupus Erythematosus.
    https://doi.org/10.1016/j.autrev
  4. Academic Endocrinology Research Resources.ย Autoimmune and Metabolic Endocrine Disorders.
    https://www.endocrine.org/
  5. Life Journal. (2024).ย Vitamin D Levels as a Marker of Severe SARS-CoV-2 Infection.
    https://doi.org/10.3390/life

 

Amy Miner Ross | immunology | Best Researcher Award

Dr. Amy Miner Ross | immunology | Best Researcher Award

Associate Professor, Faculty Coordinator for Accreditation and Quality Improvement, OHSU, United Statesย ย ๐Ÿฅ๐Ÿ“š

Dr. Amy Miner Ross, PhD, R.N., C.N.S., is an esteemed nursing scholar and researcher specializing in inflammatory responses in stroke and transient ischemic attacks. As an Associate Professor at Oregon Health & Science University, she has significantly contributed to health systems and organizational leadership. Her extensive experience spans clinical practice, research, and academic leadership, fostering advancements in neuroscience nursing. With numerous funded research projects, she explores immune responses, stroke outcomes, and innovative healthcare solutions. Dr. Ross’s dedication to nursing education, research, and leadership continues to shape the future of nursing science.

Profile

Scopus

Education ๐ŸŽ“๐Ÿ“–

Dr. Ross holds a PhD in Nursing from Oregon Health & Science University (2006), where she focused on inflammatory responses in stroke/TIA. She earned her MS in Nursing (1987) from the University of California, San Francisco, specializing in physiological nursing and physiology. Her foundational studies include a BS in Nursing from the University of San Francisco (1978) and an AS in Science from City College of San Francisco (1974). Her educational background laid the foundation for her expertise in neuroscience nursing and research.

Professional Experience ๐Ÿฅ๐Ÿ”ฌ

Dr. Ross has been an integral part of Oregon Health & Science University since 2006, serving as an Associate Professor and holding leadership roles, including Director of Health Systems & Organizational Leadership. She has extensive experience in clinical research, having worked as a Neuroscience Clinical Nurse Specialist at Rogue Valley Medical Center and as a Clinical Nurse Specialist at UCSF. Her diverse experience spans academia, research consultancy, and direct patient care, shaping her expertise in stroke research, healthcare leadership, and nursing education.

Research Interests ๐Ÿง ๐Ÿ”ฌ

Dr. Ross’s research focuses on inflammatory responses in stroke and TIA, immune system modulation, and neurological outcomes. She investigates immune senescence, stroke-induced immunodeficiency, and environmental health interventions like virtual reality greenspace to enhance immune recovery. Her work aims to improve stroke care, patient outcomes, and healthcare system efficiencies. She has secured multiple research grants to explore biomarkers, neurological worsening, and stroke-related infections.

Awards & Honors ๐Ÿ†๐ŸŽ–๏ธ

Dr. Ross has received numerous research grants and awards, including funding from Sigma Theta Tau International and the Neuroscience Nursing Foundation. She has been a recipient of internal and external research grants, supporting groundbreaking studies in stroke-induced immunodeficiency and immune response trajectories. Her leadership in health systems research and academia has been widely recognized, solidifying her reputation as a distinguished nursing scientist.

Publications ๐Ÿ“š๐Ÿ“

Ross, A.M., et al. (2021). Delineating risk groups for infection and neurological worsening in stroke-induced immunodeficiency. Journal of Neuroscience Nursing. [Cited by 35] ๐Ÿ”—

Ross, A.M., et al. (2019). The role of immune senescence in acute ischemic stroke outcomes. Stroke Research & Treatment. [Cited by 50] ๐Ÿ”—

Ross, A.M., et al. (2017). Biomarkers for predicting pro- and anti-inflammatory phases in stroke patients. Neuroimmunology Journal. [Cited by 42] ๐Ÿ”—

Ross, A.M., et al. (2015). Impact of norepinephrine sensitivity on lymphocyte function in ischemic stroke. Journal of Clinical Nursing Science. [Cited by 28] ๐Ÿ”—

Conclusion ๐Ÿ“

In conclusion, Dr. Amy Miner Ross is an excellent candidate for the Best Researcher Award. Her distinguished academic achievements, groundbreaking research, and leadership in nursing science make her an influential figure in the field. Dr. Ross’s commitment to advancing healthcare solutions and improving stroke care outcomes positions her as a deserving recipient of this prestigious award. ๐ŸŒŸ

Carina Gabriela Uasuf | Allergology | Women Researcher Award

Dr Carina Gabriela Uasuf | Allergology | Women Researcher Award

Ricercatore, IFT – CNR, Italyย ย ๐Ÿ“œ

Carina Gabriela Uasuf, a dedicated medical researcher and physician, specializes in Allergology and Clinical Immunology. Originally from Argentina, she has been residing in Italy, where she holds citizenship. With extensive expertise in immuno-allergological research and clinical practices, Carina is a distinguished member of leading scientific communities, actively contributing to advancements in healthcare.

Profile

orcid

Education ๐ŸŽ“

Carina graduated as a Surgeon in 1995 from the Faculty of Medical Sciences, Rosario, Argentina. She further specialized in Allergology and Clinical Immunology in 2002 at the Order of Physicians of Santa Fe, Argentina. Her qualifications were later homologated by Italyโ€™s Ministry of Health in 2005, cementing her international credentials.

Professional Experience ๐Ÿ’ผ

Carina has served as a Medical Researcher III at IFT, C.N.R., Palermo, since 2008, leading immuno-allergological clinical research. She also practiced as a medical specialist in Allergology at Ospedale Buccheri La Ferla FatebeneFratelli (2011โ€“2014). Her career includes research roles in Argentina, the UK, and the USA, focusing on innovative diagnostic and therapeutic approaches in allergology.

Research Interests ๐Ÿ”ฌ

Carinaโ€™s research encompasses molecular diagnostics of allergies, innovative methods in food and drug allergy detection, and the analysis of airway inflammation markers. Her work integrates cutting-edge techniques like induced sputum analysis, nitric oxide measurement, and flow cytometry.

Awards ๐Ÿ†

Carina Gabriela Uasuf has been recognized internationally for her exceptional contributions to Allergology and Clinical Immunology. She received the Best Abstract Prize in Food Allergy at the prestigious EAACI conference in Copenhagen in 2014, followed by the Best Abstract Prize in Allergic Inflammation at EAACI 2015 in Barcelona. Beyond these accolades, Carina is a sought-after speaker and moderator, actively participating in numerous regional, national, and international conferences, where she shares her expertise and fosters collaborative advancements in her field.

Publications Top Notes๐Ÿ“š

Uasuf C.G. et al., “Title,” Journal Name, 2023. [Cited by: 15]. Read here.

Uasuf C.G. et al., “Title,” Journal Name, 2022. [Cited by: 12]. Read here.

Uasuf C.G. et al., “Title,” Journal Name, 2021. [Cited by: 10]. Read here.

Conclusion

Dr. Carina Gabriela Uasuf is an outstanding candidate for the Research for Women Researcher Award, given her remarkable expertise, international recognition, and impactful contributions to Allergology and Clinical Immunology. Addressing areas like mentorship, advocacy, and public outreach could further bolster her application, ensuring her achievements resonate beyond academia into broader societal impact.

Mohamed Eltokhy | Immunology | Best Researcher Award

Mr Mohamed Eltokhy | Immunology | Best Researcher Award

MSc., PhD Candidate, TTUHSC, Egyptย 

Mohamed Ashraf Eltokhy is an Assistant Lecturer at the Graduate School of Biomedical Sciences at Texas Tech University Health Sciences Center (TTUHSC) in Abilene, Texas, and a PhD student specializing in Immunotherapeutic & Biotechnology. With a strong background in pharmacy and microbiology, his research is focused on cancer therapeutics, particularly in developing novel anticancer agents and advancing drug discovery mechanisms. His goal is to contribute to more effective and safer cancer treatments. Mohamed is also the CEO of Neopurpose Therapeutics, where he focuses on strategic decision-making, business development, and customer acquisition.

Profile

Orcid

๐Ÿ“š Education

Mohamed holds a Bachelor of Science in Pharmaceutical Science from Misr International University (MIU) in Cairo, Egypt, where he graduated with honors. He completed his MSc in Microbiology & Immunology from Al-Azhar University, also in Cairo. Currently, he is pursuing a PhD at Texas Tech University Health Sciences Center, where he maintains an impressive GPA of 3.948.

๐ŸŽ“ Experience

Mohamed’s career combines academic teaching and hands-on research. He serves as an Assistant Lecturer at MIU in Cairo, where he teaches microbiology, immunology, and biochemistry courses. Additionally, he is a Guest Researcher at Leiden University in the Netherlands and has worked as a pharmacist and in pharmaceutical regulatory affairs in Egypt. His work in cancer therapeutics is complemented by his leadership role as CEO of Neopurpose Therapeutics.

๐Ÿงฌ Research Interests

His research interests primarily focus on cancer treatment, specifically the development of novel anticancer agents and their mechanistic studies. He is also exploring the use of 3D bioprinted tumor-on-chip models for drug discovery and the individualization of chemotherapy regimens. His work includes in vitro and in vivo screening of agents and the study of their safety and efficacy.

๐Ÿ† Awards

Mohamed’s dedication to research and academic excellence has been recognized with multiple awards, including the Texas Tech Accelerator Program Award in 2024 and a late-breaking poster presentation award at the AACR conference in 2024. He has also received accolades for his contributions to the Microbiology & Immunology department at MIU, including academic excellence awards in 2021 and 2022, as well as the Top-Ranked Graduation Award in 2015 for achieving the highest GPA.

๐Ÿ“– Publications Top Notes

Patel, B., Silwal, A., Eltokhy, M. A., Gaikwad, S., Curcic, M., Patel, J., & Prasad, S. (2024). Deciphering CD59: Unveiling Its Role in Immune Microenvironment and Prognostic Significance. Cancers, 16(21), 3699.
Link to article

Eltokhy, M.A., Saad, B.T., Eltayeb, W.N., et al. (2024). Metagenomic nanopore sequencing for exploring the nature of antimicrobial metabolites of Bacillus haynesii. AMB Express, 14, 52.
Link to article

Eltokhy, M.A., Saad, B.T., Eltayeb, W.N., et al. (2021). Exploring the Nature of the Antimicrobial Metabolites Produced by Paenibacillus ehimensis Soil Isolate MZ921932 Using a Metagenomic Nanopore Sequencing Coupled with LC-Mass Analysis. Journal of Antibiotics (MDPI).
Link to article

Eltokhy, M.A., Saad, B.T., Eltayeb, W.N., et al. (2021). A metagenomic nanopore sequence analysis combined with conventional screening and spectroscopic methods for deciphering the antimicrobial metabolites produced by Alcaligenes faecalis soil isolate MZ921504. Journal of Antibiotics (MDPI).
Link to article

Eassa HA, Eltokhy MA, Fayyaz HA, et al. (2020). Current Topical Strategies for Skin-Aging and Inflammaging Treatment: Science versus Fiction. Europe PMC.
Link to article

Conclusion

In conclusion, Mohamed Ashraf Eltokhy is a highly deserving candidate for the Best Researcher Award, given his consistent dedication to advancing cancer research and his ongoing contributions to drug discovery. His work holds immense potential for improving cancer treatments and diagnostics, and with further growth in bioinformatics and clinical research, his impact on the field will undoubtedly increase. His leadership in both academic and entrepreneurial settings reflects his commitment to translating research into real-world applications.

Ms. Sarah Saci | Immunology and Microbiology | Young Scientist Award-1124

Ms. Sarah Saci | Immunology and Microbiology | Young Scientist Award

Phd student, University of Mouloud Mammeri Tizi-Ouzou, Algeria

Ms. Sarah Saci, a PhD student in Immunology and Microbiology at the University of Mouloud Mammeri Tizi-Ouzou, Algeria, has been honored with the prestigious Young Scientist Award ๐Ÿ…. Her groundbreaking research in the fields of immunology and microbiology has earned her this esteemed recognition ๐ŸŒŸ. Sarah’s dedication and innovative approach to her studies have made a significant impact, showcasing her exceptional talent and passion for scientific discovery ๐Ÿ”ฌ. Congratulations to Ms. Saci for this remarkable achievement! ๐ŸŽ‰

Profile ๐Ÿ“œ

orcid

Academic and Professional Background ๐ŸŒฟ

Mr. Sarah Saci is a PhD candidate in microbiology, specializing in the mechanisms of action of medicinal plants. His research focuses on combining plant extracts with antibiotics to restore their effectiveness in the poultry sector ๐Ÿ”. By exploring the natural properties of plants, Sarah aims to develop therapeutic alternatives to combat antimicrobial resistance ๐ŸŒฑ. His innovative approach not only addresses a critical issue in veterinary medicine but also contributes to the sustainability and safety of the poultry industry. Through this work, Sarah is advancing our understanding of natural antimicrobial agents and their potential applications in animal health ๐ŸŒฟ.

Research and Innovations ๐Ÿ”ฌ

Mr. SACI Sarah has made significant contributions to microbiology by researching the synergistic effects of medicinal plant extracts and antibiotics to combat antimicrobial resistance in poultry ๐Ÿ“. Her innovative approach aims to restore the efficacy of antibiotics and provide sustainable alternatives in the poultry industry. Through her work, she has advanced our understanding of natural antimicrobial agents and their potential applications in veterinary medicine, addressing critical issues in animal health and food safety ๐ŸŒพ. This research not only enhances antibiotic effectiveness but also promotes safer, more sustainable practices in the poultry sector.

Award Category Preferences ๐Ÿ…

Mr. SACI Sarah is a dedicated researcher specializing in microbiology, with a particular focus on antimicrobial resistance ๐Ÿฆ . His work extensively explores the use of medicinal plants as a natural remedy to combat resistant pathogens ๐ŸŒฟ. Additionally, he is deeply involved in veterinary medicine, striving to improve animal health and welfare through innovative solutions ๐Ÿพ. His research is particularly impactful in the field of avian health, where he aims to enhance the effectiveness of treatments in the poultry industry ๐Ÿ”. Sarah’s commitment to these areas highlights his passion for advancing scientific knowledge and improving health outcomes ๐Ÿ“š.

Publications Top Notes๐Ÿ“šโœ๏ธ๐Ÿ“